Isoxsuprine

This classification denotes a vasodilating agent and beta-adrenergic agonist with the molecular formula C18H23NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R15UI3245N, chemically known as benzyl alcohol, p-hydroxy-alpha-(1-((1-methyl-2-phenoxyethyl)amino)ethyl)- but generally known as isoxsuprine, which bears US NIH Compound Identifier 3783. European Medicines Agency schedules Isoxsuprine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08345MIG. The term ISOXSUPRINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules isoxsuprine in its Anatomical Therapeutic Chemical (ATC) Classification. ISOXSUPRINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule isoxsuprine under HS 29225000 and SITC 51467. As of Q4 2014, ISOXSUPRINE remains the US FDA Preferred Term for this commodity. Isoxsuprine bears US NLM identifiers UMLS ID C0022267 and NCI Concept Code C61795. SMILES: OC(C(NC(COC1CCCCC1)C)C)C1CCC(O)CC1.